Renal hypertrophy as a prognostic index for the progression of diabetic renal disease in non-insulin-dependent diabetes mellitus

Journal of Diabetes and Its Complications

Volumn 7, Issue 1, 1993, Pages 28-33

  Inomata, Shigeki ^a  

^a Yuri Kumiai General Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ENALAPRIL; GLYCOSYLATED HEMOGLOBIN; METOPROLOL; NIFEDIPINE;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA;

ADOLESCENT; ADULT; ANTIHYPERTENSIVE AGENTS; COMPARATIVE STUDY; DIABETES MELLITUS, NON-INSULIN-DEPENDENT; DIABETIC NEPHROPATHIES; FEMALE; HUMAN; HYPERTROPHY; KIDNEY; MALE; MIDDLE AGE; PROGNOSIS;

EID: 0027141527     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/1056-8727(93)90020-Y     Document Type: Article

References (33)

1. Renal hypertrophy in streptozotocin-diabetic rats
2. 3-thymidine uptake in diabetic and uninephrectomized rats
3. Kidney size in diabetes mellitus
4. Increased kidney size and glomerular filtration rate in early juvenile diabetes
5. Relation of kidney size to kidney function in early insulin-dependent diabetes
6. Increased kidney size, glomerular filtration rate and renal plasma flow in short-term insulin-dependent diabetics
7. Kidney size and glomerular filtration rate in type 1 (insulin-dependent) diabetes mellitus revisited [letter]
8. The kidney size in diabetes: Significance of the early abnormalities
9. Kidney function and size in diabetics before and during initial insulin treatment
10. The effect of six months continuous subcutaneous insulin infusion on kidney function and size in insulin-dependent diabetics
11. Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulin-dependent diabetes
12. Effect of continuous subcutaneous insulin infusion on kidney function and size in IDDM patients: A 2 year function and size
13. Predicting diabetic nephropathy in insulin-dependent patients
14. Early glomerular hyperfiltration in insulin-dependent diabetics and late nephropathy
15. Normal renal size: An absolute criterion
16. Relationship between urinary albumin excretion rate and renal histology in non-insulin dependent diabetes mellitus: With reference to the clinical significance of microalbuminuria
17. Relation of renal growth to diabetic glomerulosclerosis
18. Effect of diabetes mellitus on renal metabolism
19. Renal hypertrophy in experimental diabetes. Changes in pentose phosphate pathway activity
20. Physiological effects of growth hormone and insulin-like growth factor I on the kidney
21. Somatostatin analogue administration prevents increase in kidney somatomedin C and uninephrectomized rats
22. Renal response to intravenous somatostatin in insulin-dependent diabetic patients and normal subjects
23. Histopathology associated with elevated levels of growth hormone and insulin-like growth factor 1 in transgenic mice
24. Increased kidney size and glomerular filtration rate in untreated juvenile diabetics: Normalization by insulin treatment
25. Effect of strict glycemic control on renal hemodynamic response to amino acids and renal enlargement in insulin-dependent diabetes mellitus
26. Prognostic implication of renal hypertrophy in diabetes mellitus
27. Hyperfiltration in patients with type 2 diabetes mellitus
28. Onset and progression of diabetic glomerulosclerosis. A pathogenetic role of segmentally turbulent glomerular circulation
29. Glomerular volume in type 2 (noninsulin-dependent) diabetes estimated by a direct and unbiased steologic method
30. Relationship of renal size to nephropathy in type 1 (insulin-dependent) diabetes
31. Kidney function and cardiovascular risk factors in non-insulin-dependent diabetics (NIDDM) with microalbuminuria
32. Somatostatin analogue, Ocreo-tide, reduces increased glomerular filtration rate and kidney size in insulin-dependent diabetes
33. Diabetic nephropathy Can the natural history be modified?